News Archive - School of Medicine

Supercomputing Drug Screening For Deadly Heart Arrhythmias

Using supercomputers, scientists have developed for the first time a way to screen drugs through their chemical structures for induced arrhythmias.

Ruth S. Waterman, MD, Named Chair of the Department of Anesthesiology

Ruth S. Waterman, MD, has been named chair of the Department of Anesthesiology at University of California San Diego School of Medicine and UC San Diego Health.

Introducing the UC San Diego Return to Learn Program

Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.

How are You Doing? Researchers Hope to Measure Well-Being at Global Scale

With website, UC San Diego School of Medicine scientists will monitor health and well-being during and after pandemic.

$55M NIH Grant Advances Clinical and Translational Research at UC San Diego

The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health.

UC San Diego Health Offers Virtual Appointments to Patients with COVID-19

UC San Diego Health now offers a telemedicine clinic to help patients with COVID-19 recover at home.

Clinical Trial to Investigate whether Hypertension Drug Ameliorates COVID-19 Severity

UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

UC San Diego Health Nationally Recognized with ‘A’ Grades for Safety

UC San Diego Health has been awarded double ‘A’ grades for the spring 2020 Leapfrog Hospital Safety Grade.

Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia

UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.

Loss of Smell Associated with Milder Clinical Course in COVID-19

Researchers at UC San Diego Health report in newly published findings that olfactory impairment suggests the resulting COVID-19 disease is more likely to be mild to moderate, a potential early indicator that could help health care providers determine which patients may require hospitalization.